Clinical trial
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
NCT00109850 · SWOG Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00109850 |
|---|---|
| Title | S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer |
| Official title | Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Biological, Drug, Radiation |
| Interventions | cetuximab, cisplatin, irinotecan hydrochloride, radiation therapy |
| Enrollment | 22 |
| Start date | May 1, 2005 |
| Primary completion | Sep 1, 2009 |
| Completion | May 1, 2012 |
| First posted | May 4, 2005 |
| Last update posted | Nov 18, 2015 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: